BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24066175)

  • 1. The trade-off between accuracy and accessibility of syphilis screening assays.
    Smit PW; Mabey D; Changalucha J; Mngara J; Clark B; Andreasen A; Todd J; Urassa M; Zaba B; Peeling RW
    PLoS One; 2013; 8(9):e75327. PubMed ID: 24066175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay.
    Henrich TJ; Yawetz S
    Sex Transm Dis; 2011 Dec; 38(12):1126-30. PubMed ID: 22082723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the Greater Toronto Area.
    Mishra S; Boily MC; Ng V; Gold WL; Okura T; Shaw M; Mazzulli T; Fisman DN
    Sex Transm Dis; 2011 Mar; 38(3):190-6. PubMed ID: 20706176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Treponema pallidum-specific captia syphilis IgG assay in conjunction with the rapid plasma reagin to test for syphilis.
    Reisner BS; Mann LM; Tholcken CA; Waite RT; Woods GL
    J Clin Microbiol; 1997 May; 35(5):1141-3. PubMed ID: 9114396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of diagnostic serological results in cases of suspected primary syphilis infection.
    Gratzer B; Pohl D; Hotton AL
    Sex Transm Dis; 2014 May; 41(5):285-9. PubMed ID: 24722379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis.
    Chuck A; Ohinmaa A; Tilley P; Singh A; Jacobs P
    Int J STD AIDS; 2008 Jun; 19(6):393-9. PubMed ID: 18595877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the serodia Treponema pallidum particle agglutination, the Murex Syphilis ICE and the Enzywell TP tests for serodiagnosis of syphilis.
    Aktas G; Young H; Moyes A; Badur S
    Int J STD AIDS; 2005 Apr; 16(4):294-8. PubMed ID: 15899082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population.
    Wong EH; Klausner JD; Caguin-Grygiel G; Madayag C; Barber KO; Qiu JS; Liska S; Pandori MW
    Sex Transm Dis; 2011 Jun; 38(6):528-32. PubMed ID: 21233789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistency Between Treponema pallidum Particle Agglutination Assay and Architect Chemiluminescent Microparticle Immunoassay and Characterization of Inconsistent Samples.
    Zhiyan L; Meiling W; Ping L; Jinhua D; Zhenlin Y; Zhenru F
    J Clin Lab Anal; 2015 Jul; 29(4):281-4. PubMed ID: 24840601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays.
    Maple PA; Ratcliffe D; Smit E
    Clin Vaccine Immunol; 2010 Nov; 17(11):1718-22. PubMed ID: 20844087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of reverse sequence algorithm for syphilis diagnosis using optimal treponemal screening assay signal-to-cutoff ratio.
    Serhir B; Labbé AC; Doualla-Bell F; Simard M; Lambert G; Trudelle A; Longtin J; Tremblay C; Fortin C
    PLoS One; 2018; 13(9):e0204001. PubMed ID: 30212544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of point-of-care rapid combination syphilis-HIV-HCV tests.
    Hess KL; Fisher DG; Reynolds GL
    PLoS One; 2014; 9(11):e112190. PubMed ID: 25375138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of syphilis assays in detecting different stages of early syphilis.
    Manavi K; Young H; McMillan A
    Int J STD AIDS; 2006 Nov; 17(11):768-71. PubMed ID: 17062183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syphilis Immunoassay Signal Strength Correlates with Active Infection in Pregnant Women.
    Zofkie AC; Seasely AR; Gaffney D; Rogers VL; Mcintire DD; Roberts SW; Adhikari EH
    Am J Perinatol; 2020 Jun; 37(7):671-678. PubMed ID: 31910464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Chemiluminescent Microparticle Immunoassay in Screening for Syphilis in Pregnant Women from Low-Prevalence, Resource-Limited Setting.
    Boonchaoy A; Wongchampa P; Hirankarn N; Chaithongwongwatthana S
    J Med Assoc Thai; 2016 Feb; 99(2):119-24. PubMed ID: 27249890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the LIAISON chemiluminescence immunoassay for diagnosis of syphilis.
    Knight CS; Crum MA; Hardy RW
    Clin Vaccine Immunol; 2007 Jun; 14(6):710-3. PubMed ID: 17460119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an automated rapid plasma reagin (RPR) test with the conventional RPR card test in syphilis testing.
    Lee JH; Lim CS; Lee MG; Kim HS
    BMJ Open; 2014 Dec; 4(12):e005664. PubMed ID: 25552608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for performing treponemal tests in reverse-sequence algorithms of syphilis diagnosis.
    Yi J; Choi W; Shin S; Choi J; Kim H; Chung HJ; Moon HW; Hur M; Yun YM
    Clin Biochem; 2019 Jan; 63():121-125. PubMed ID: 30287231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferable procedure for the screening of syphilis in clinical laboratories in China.
    Wang KD; Xu DJ; Su JR
    Infect Dis (Lond); 2016; 48(1):26-31. PubMed ID: 26313112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for antibodies against Treponema pallidum with chemiluminescent microparticle immunoassay: analysis of discordant serology results and clinical characterization.
    Li Z; Feng Z; Liu P; Yan C
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):588-92. PubMed ID: 26680646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.